Clinical Trial Update: Evaluate the Safety and Efficacy of Autologous Tumor-infiltrating Lymphocyte in Patients With Refractory Melanoma Who Failed to Immune Checkpoint Inhibitors [NA]

View source ↗

Summary

A clinical trial update investigating autologous tumor-infiltrating lymphocyte therapy for melanoma patients who failed immune checkpoint inhibitors; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Autologous tumor-infiltrating lymphocyte (TIL) therapy (tumor infiltrating lymphocytes (TIL) therapy)

Snippet

Sponsor: Samsung Medical Center | Conditions: Melanoma | NA | Status: NOT_YET_RECRUITING